Melanoma Promotion after Photodynamic Therapy of a Suspected Bowen’s Disease Lesion

We report on a 61-year-old male patient who developed a melanoma at the site of a suspected Bowen’s lesion on the right cheek. This lesion had evolved for years and had been treated using photodynamic therapy (PDT) in an outpatient facility. Only a couple of months after a single PDT treatment, a melanoma was histologically diagnosed. After excision, multiple metastases were found. The therapeutic strategy comprised re-excision, neck dissection and lateral parotidectomy – due to a metastasis – as well as subsequent α-interferon injections. The possible role of PDT in the promotion of melanoma is discussed.

[1]  C. Morton,et al.  Guidelines for topical photodynamic therapy: update , 2008, The British journal of dermatology.

[2]  E. Tonin,et al.  Melanoma and Immunosuppression , 2008, Dermatology.

[3]  Michael Landthaler,et al.  Photodynamic Therapy in Dermatology – an Update 2008 , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[4]  M. Korbelik,et al.  Acute phase response induction by cancer treatment with photodynamic therapy , 2008, International journal of cancer.

[5]  N. Oleinick,et al.  Protection by Bcl-2 against apoptotic but not autophagic cell death after photodynamic therapy , 2008, Autophagy.

[6]  G. Jemec,et al.  Pain and Photodynamic Therapy , 2007, Dermatology.

[7]  H. Takahashi,et al.  ATX‐S10(Na)–photodynamic therapy is less carcinogenic for mouse skin compared with ultraviolet B irradiation , 2005, The British journal of dermatology.

[8]  M. Landthaler,et al.  Photodynamic therapy in dermatology – an update , 2005, Photodermatology, photoimmunology & photomedicine.

[9]  Y. Surh,et al.  Protective effects of hemin and tetrakis(4-benzoic acid)porphyrin on bacterial mutagenesis and mouse skin carcinogenesis induced by 7, 12-dimethylbenz[a]anthracene. , 2000, Mutation research.

[10]  C. Elmets,et al.  Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. , 1986, Cancer research.

[11]  Aditya K. Gupta,et al.  Photodynamic therapy and topical aminolevulinic acid: an overview. , 2003, American journal of clinical dermatology.

[12]  H. Kerl,et al.  Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site. , 1997, Dermatology.

[13]  A. Abramson,et al.  Clinical exacerbation of systemic lupus erythematosus after photodynamic therapy of laryngotracheal papillomatosis , 1993, Lasers in surgery and medicine.